Inflammatory Bowel Disease Signal Associated with Dipeptidyl Peptidase - 4 Inhibitor Exposure in Type 2 Diabetes Mellitus: A Retrospective Case – Control Study from a Tertiary Care Hospital
International Journal of Experimental and Biomedical Research · 16.04.2026 · 5 (2) · 29-40
DOI: 10.26452/ijebr.v5i2.571 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Experimental and Biomedical Research, online erschienen am 16.04.2026. Verfasst von {"name":"Guddanti Rajasree","email":"shalinichevuru99@gmail.com","affiliation" und 6 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
The present study aimed to evaluate the possible association between the use of DPP - 4 inhibitors and the occurrence of inflammatory bowel disease in patients with Type 2 Diabetes Mellitus in a South Indian tertiary care hospital. A retrospective case – contr ol study was conducted using hospital medical records. A total of 132 patients were included, comprising 66 cases (patients with T2DM and IBD) and 66 controls (patients with T2DM without IBD). Data regarding demographic characteristics, duration of diabete s, antidiabetic medication use, including DPP - 4 inhibitors, and laboratory parameters were collected using a structured Case Record Form. Diagnosis of IBD was confirmed based on gastroenterologist documentation, supported by colonoscopy findings and histop athological reports where available. The Chi - square test or Fisher’s exact test was applied as appropriate, and a p - value < 0.05 was considered statistically significant. Exposure to DPP - 4 inhibitors was observed in 9.1% of patients in the IBD group and 22 .7% of patients in the non - IBD group. A statistically significant association was observed between DPP - 4 inhibitor exposure and the occurrence of IBD (p = 0.038), with an odds ratio of approximately 0.34. However, the odds ratio of less than 1 indicates lo wer odds of IBD among patients exposed to DPP - 4 inhibitors and should not be interpreted as a protective effect due to the retrospective design and small number of exposed patients. No statistically significant association was observed between the duration of DPP - 4 inhibitor use and the development of IBD (p = 0.64). Similarly, the duration of diabetes mellitus was not significantly associated with the occurrence of IBD (p = 0.61).
Zitieren
APA
Rajasree","email":"shalinichevuru99@gmail.com","affiliation", N., pujitha","email":"shalinichevuru99@gmail.com","affiliation":, N., pravallika","email":"shalinichevuru99@gmail.com","affiliatio, N., shabna","email":"shalinichevuru99@gmail.com","affiliation":", N., Nawaz","email":"shalinichevuru99@gmail.com","affiliation":"I, N., Shalini","email":"shalinichevuru99@gmail.com","affiliat, N. B., & chandra","email":"shalinichevuru99@gmail.com","affi, N. P. (2026). Inflammatory Bowel Disease Signal Associated with Dipeptidyl Peptidase - 4 Inhibitor Exposure in Type 2 Diabetes Mellitus: A Retrospective Case – Control Study from a Tertiary Care Hospital. International Journal of Experimental and Biomedical Research, 5(2), 29-40. https://doi.org/10.26452/ijebr.v5i2.571
Vancouver
Rajasree","email":"shalinichevuru99@gmail.com","affiliation" N, pujitha","email":"shalinichevuru99@gmail.com","affiliation": N, pravallika","email":"shalinichevuru99@gmail.com","affiliatio N, shabna","email":"shalinichevuru99@gmail.com","affiliation":" N, Nawaz","email":"shalinichevuru99@gmail.com","affiliation":"I N, Shalini","email":"shalinichevuru99@gmail.com","affiliat NB, et al. Inflammatory Bowel Disease Signal Associated with Dipeptidyl Peptidase - 4 Inhibitor Exposure in Type 2 Diabetes Mellitus: A Retrospective Case – Control Study from a Tertiary Care Hospital. International Journal of Experimental and Biomedical Research. 2026;5(2):29-40. doi:10.26452/ijebr.v5i2.571
BibTeX
@article{Rajasreeemailshalinichevurugmailcomaffiliation2026,
author = {Rajasree","email":"shalinichevuru99@gmail.com","affiliation", "name":"Guddanti and pujitha","email":"shalinichevuru99@gmail.com","affiliation":, "name":"Katteti and pravallika","email":"shalinichevuru99@gmail.com","affiliatio, "name":"Kommala and shabna","email":"shalinichevuru99@gmail.com","affiliation":", "name":"Shaik and Nawaz","email":"shalinichevuru99@gmail.com","affiliation":"I, "name":"Shaik and Shalini","email":"shalinichevuru99@gmail.com","affiliat, "name":"Chevuru Baby and chandra","email":"shalinichevuru99@gmail.com","affi, "name":"Yadala prapurna},
title = {Inflammatory Bowel Disease Signal Associated with Dipeptidyl Peptidase - 4 Inhibitor Exposure in Type 2 Diabetes Mellitus: A Retrospective Case – Control Study from a Tertiary Care Hospital},
journal = {International Journal of Experimental and Biomedical Research},
year = {2026},
volume = {5},
number = {2},
pages = {29--40},
doi = {10.26452/ijebr.v5i2.571}
}
EUVIMED